Loading the records…
Rob Bresnahan
RepublicanPA08•house•Filed Apr 28, 2025
View all of Rob Bresnahan's trades →23 total filings on record
Rob Bresnahan (R-PA) sold $15K-$50K of $ACN (Accenture plc Class A Ordinary Shares (ACN)) on Apr 8, 2025, part of 52 transactions in this filing.
Transactions
52
Companies
52
Largest Trade
$15K-$50K
Timing Flags
None
Companies in this filing · 52
Price Movement Since Trade
How the largest positions have moved from the trade date to the most recent close.
$ACN✓ SMART SELL
Information Technology
Trade Day
$281.39
Apr 8, 2025
Current
$178.36
Apr 24, 2026
Change
-36.61%
$-103.03
Information Technology
$OXY✗ BAD SELL
Energy
Trade Day
$36.11
Apr 8, 2025
Current
$57.12
Apr 24, 2026
Change
+58.18%
+$21.01
Health Care
$TXN✗ BAD SELL
Trade Day
$146.01
Apr 8, 2025
Current
$277.14
Apr 24, 2026
Change
+89.81%
+$131.13
Health Care
Showing the 6 largest positions. See every transaction in the table below.
🔒
Sign Up to See More
See the full trade breakdown, suspicious timing flags, and how this filing connects to active legislation.
Get Free Access →Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| SELL | $ACN | Accenture plc Class A Ordinary Shares (ACN) | $15K-$50K | $281.39 | $178.36 | -36.6% | Apr 8, 2025 |
| SELL | $AMD | Advanced Micro Devices, Inc. (AMD) | $15K-$50K | $78.21 | — | — | Apr 8, 2025 |
| SELL | $OXY | Occidental Petroleum Corporation Common Stock (OXY) | $15K-$50K | $36.11 | $57.12 | +58.2% | Apr 8, 2025 |
| SELL | $PFE | Pfizer, Inc. Common Stock (PFE) | $15K-$50K | $21.84 | — | — | Apr 8, 2025 |
| SELL | $TXN | Texas Instruments Incorporated - Common Stock (TXN) | $15K-$50K | $146.01 | $277.14 | +89.8% | Apr 8, 2025 |
| SELL | $TMO | Thermo Fisher Scientific Inc Common Stock (TMO) | $15K-$50K | $419.31 | — | — | Apr 8, 2025 |
| SELL | $A | Agilent Technologies, Inc. Common Stock (A) | $1K-$15K | $99.29 | — | — | Apr 8, 2025 |
| SELL | $ABNB | Airbnb, Inc. - Class A Common Stock (ABNB) | $1K-$15K | $105.69 | $142.82 | +35.1% | Apr 8, 2025 |
| SELL | $GOOGL | Alphabet Inc. - Class A Common Stock (GOOGL) | $1K-$15K | $144.70 | — | — | Apr 8, 2025 |
| PARTIAL SELL | $GOOG | Alphabet Inc. - Class C Capital Stock (GOOG) | $1K-$15K | $146.58 | — | — | Apr 8, 2025 |
SELL$15K-$50K
$ACNAccenture plc Class A Ordinary Shares (ACN)
$281.39 \u2192 $178.36-36.6%
Apr 8, 2025 \u2022 self
SELL$15K-$50K
$OXYOccidental Petroleum Corporation Common Stock (OXY)
$36.11 \u2192 $57.12+58.2%
Apr 8, 2025 \u2022 self
SELL$15K-$50K
$TXNTexas Instruments Incorporated - Common Stock (TXN)
$146.01 \u2192 $277.14+89.8%
Apr 8, 2025 \u2022 self
SELL$15K-$50K
$TMOThermo Fisher Scientific Inc Common Stock (TMO)
$419.31 \u2192 N/A
Apr 8, 2025 \u2022 self
SELL$1K-$15K
$ABNBAirbnb, Inc. - Class A Common Stock (ABNB)
$105.69 \u2192 $142.82+35.1%
Apr 8, 2025 \u2022 self
SELL$1K-$15K
$GOOGLAlphabet Inc. - Class A Common Stock (GOOGL)
$144.70 \u2192 N/A
Apr 8, 2025 \u2022 self
PARTIAL SELL$1K-$15K
$GOOGAlphabet Inc. - Class C Capital Stock (GOOG)
$146.58 \u2192 N/A
Apr 8, 2025 \u2022 self
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
BillS1407neutral
ABC Safe Drug Act
The ABC Safe Drug Act (S. 1407) is in early legislative stages, having been referred to the Senate Finance Committee. It phases in restrictions on federal health programs purchasing drugs with Chinese active ingredients by 2030 and provides temporary tax incentives for domestic pharmaceutical manufacturing. Major pharma stocks ($PFE, $MRK, $JNJ, $LLY, $AMGN) show mixed but broadly negative 7-day changes, reflecting sector headwinds rather than this nascent bill. No market-moving impact is imminent.
Apr 10, 2025
AMGNLLYMRKPFE
BillS1475bearish
Clean Cloud Act of 2025
The Clean Cloud Act of 2025 (S1475) imposes emissions fees and reporting requirements on US cryptocurrency mining facilities exceeding 100 kW, directly increasing operating costs for MARA, RIOT, HUT, and CLSK. The bill is in early legislative stages (referred to committee) with no companion bill signed, meaning near-term impact is limited but the direction of regulatory pressure is clear. Hardware vendors SMCI, NVDA, and AMD face tempered demand risk from this customer segment if the bill advances.
Apr 10, 2025
CLSKHUTMARARIOT
BillS1410bullish
Find It Early Act
The Find It Early Act (S.1410), introduced in April 2025, would mandate no-cost-sharing coverage for advanced breast imaging for high-risk individuals and those with dense breast tissue. The bill is in early legislative stages (referred to committee) with no funding authorized. Real market data shows GEHC has fallen 14.88% in the last 7 days to $59.49, near its 52-week low, while UNH has surged 41.62% over 30 days to $370.74—moves driven by factors unrelated to this early-stage bill.
Apr 10, 2025
DGXGEHCLHUNH
BillHR2357bullish
Food Secure Strikers Act of 2025
HR 2357, the Food Secure Strikers Act of 2025, is an early-stage bill with no near-term market impact. It has been referred to subcommittee, has no floor schedule, no companion bill passage in the Senate, and no authorized funding. Walmart and Kroger face negligible SNAP volume upside from this bill in its current state. The market data shows both stocks trading near their 52-week highs with positive 7-day and 30-day momentum unrelated to this legislation.
Apr 18, 2025
KR
BillHR2823bearish
Climate Change Financial Risk Act of 2025
The Climate Change Financial Risk Act of 2025 (HR2823) would impose mandatory biennial climate risk capital evaluations and resolution plans on large U.S. banks. This creates direct compliance costs for JPMorgan, Bank of America, Citigroup, Goldman Sachs, and Morgan Stanley, while generating demand for consulting and IT services from Accenture and IBM. The bill is in early legislative stages with a companion bill in the Senate, but has low near-term passage probability given partisan dynamics and its early committee referral status.
Apr 10, 2025
ACNBACCGSIBMJPM
BillS1381bearish
Protecting Employees and Retirees in Business Bankruptcies Act of 2025
S. 1381 (Protecting Employees and Retirees in Business Bankruptcies Act of 2025) is an early-stage Senate bill that would structurally increase bankruptcy costs for labor-intensive companies. For UAL and GM, the bill elevates employee and retiree claims in Chapter 11, raising bankruptcy risk premiums. At impact score 3, near-term market effects are minimal, but the structural risk is real if the bill advances through the Judiciary Committee.
Apr 9, 2025
GMUAL
BillHR2767neutral
BRAIN Act
The BRAIN Act (HR2767) is an early-stage bill in the 119th Congress that authorizes no funding and has been referred to committee. Near-term market impact is negligible. The bill creates programmatic structures for brain tumor research, biospecimen transparency, and biomarker testing awareness, but actual market effects require future appropriations and bill text clarity. No publicly traded companies face material revenue exposure at this stage.
Apr 9, 2025
BillHR3002neutral
Homeland Security Climate Change Coordination Act
HR3002, the Homeland Security Climate Change Coordination Act, is an early-stage House bill creating a DHS internal council to coordinate climate adaptation efforts. It authorizes zero funding, no procurement, and no regulatory changes, producing no measurable near-term market impact for any public company. The bill is stuck in subcommittee with no further action since introduction over a year ago.
Apr 24, 2025
BillHR2326bullish
Dietary Guidelines Reform Act of 2025
The Dietary Guidelines Reform Act of 2025 (HR2326) extends the federal dietary guideline update cycle from 5 to 10 years, providing direct regulatory relief to large packaged food and beverage manufacturers by halving mandatory reformulation frequency. The bill is early-stage (referred to subcommittee) with bipartisan cosponsors and an identical Senate companion, indicating moderate passage potential. Real market data shows consumer staples stocks have rallied 0.43% to 6.51% over the past 7 days, with $MDLZ leading at +6.51%.
Apr 18, 2025
GISKHCKOMDLZPEP
BillHR2936neutral
Addressing Boarding and Crowding in the Emergency Department
HR2936 (ABC-ED Act) authorizes zero new funding and remains in early committee stage with no near-term market impact. The bill expands eligibility for existing public health data modernization grants to include hospital bed capacity tracking at the state and regional level, but any fiscal effect requires separate appropriations.
Apr 17, 2025
Other Filings by Rob Bresnahan
Free — no credit card
Get the next Bresnahan trade the day it's disclosed
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.